Stylus Medicine, Inc. ("Stylus"), a biotechnology company dedicated to developing transformative in vivo genetic medicines, today emerges from stealth with $85 million in financing. Stylus' funding ...

Illumina Inc. today announced the launch of DRAGENtm version 4.4 software (v4.4), the industry's most comprehensive secondary analysis solution. The latest version of DRAGEN includes out-of-the-box ...

Artificial intelligence is revolutionizing the way we care for animals. Once limited to reactive treatments at vet clinics, animal healthcare is evolving into a proactive, data-driven field where AI ...